NAD on Slim 90
This article was originally published in The Tan Sheet
Executive Summary
Claims by NMD Marketing that the weight-loss product Slim 90 "is safe" and has "no side effects" will be referred to FTC, the National Advertising Division announces Dec. 1. NMD has not responded to NAD's "repeated attempts" to obtain substantiation for the claims, which are not compliant with a recent NAD decision, in which NMD agreed to suspend six efficacy, performance and safety claims that NAD determined were not backed by reliable scientific evidence (1"The Tan Sheet" June 14, 2004, p. 11)...
You may also be interested in...
Slim 90 Weight-Loss Claims Unsubstantiated, NAD Concludes
NMD Marketing should discontinue certain claims for its Slim 90 weight-loss product in the absence of "competent and reliable scientific evidence," according to the National Advertising Division of the Council of Better Business Bureaus
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.